ArticleBMC women's health2022
The use of Method Information Index (MII) to monitor the amount of information given to women users of modern contraceptives in Indonesia: results from an analysis of the 2007, 2012 and 2017 demographic and health surveys.
Article in BMC women's health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Family planning service quality and contraceptive discontinuation among short-acting contraceptive users in Indonesia: a survival analysis of the 2017 Indonesia demographic health survey.BMC women's health · 2026Article
- Family planning exemplar country selection methodology: time lag and trends analysis.BMJ global health · 2026Article
- Measuring Informed Choice for Contraception in Burkina Faso: Comparing self-rated and researcher-ascribed measures.Social indicators research · 2025Article
- Quality of family planning counseling and associated factors among reproductive age women who are current contraceptive users at Dessie town health facilities east Amhara, 2023.BMC health services research · 2024Article
- Contraceptive use and associated factors among women with HIV receiving care at a faith-based tertiary hospital in Northern Uganda: a cross-sectional study.Therapeutic advances in reproductive healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of Method Information Index (MII) indicates whether women contraceptive users receive adequate information about all available contraceptive methods, side effects of the methods, and how to deal with the side effects if experienced-at method initiation.
objectiveThis study aims to investigate the level of MII scores or the amount of information received by married women users of five modern contraceptives at the time of initiation and changes of its determinants based on the Indonesian Demographic and Health data between 2007 and 2017.
methodsData of married women who used most common five modern contraceptive methods (the pill, injectables, implants, IUD, and female sterilization), comprised of a total unweighted sample of 35,412 users out of the 32,895; 45,607 and 49,627 women aged 15-49 in the 2007, 2012, and 2017 Indonesian Demographic and Health Survey (IDHS), respectively. The Method Information Index (MII) scores were calculated based on responses to three questions (whether women were told about method-specific side effects, advised what to do if they experienced them, and informed about other available methods). Multivariable logistic regressions with 'time' as an interaction variable were used to assess the influence of time upon the MII scores and its determinants.
resultsThe MII scores were 23.84% in 2007, 24.60% in 2012 and 28.65% in 2017. Obviously, over 70% of reproductive-age women contraceptive users were not receiving complete information about modern contraceptives at the time of initiation. After 5 years (2012), only living in the Java Bali region (AOR = 1.34, 95% CI 1.09-1.66) compared to living in other islands, and currently using injectables (AOR = 1.43, 95% CI 1.10-1.87) and currently using implants (AOR = 1.68, 95% CI 1.07-2.63) compared to currently using pills had significantly higher odds of receiving MII information. After 10 years (2017), only one variable (the 'richest' in the wealth quintile category (AOR = 0.70, 95% CI 0.50-0.99) compared to the 'poorest') still showed a significant association with receipt of complete MII information.
conclusionsDespite the fact that the MII scores increased gradually across the years, interaction with 'survey time' showed that the likelihood of receiving complete MII information was not statistically different in the 5 years (2007-2012) and in the 10 years (2007-2017) period from the reference category in 2007. The authors recommend use of the MII score as an objective measure to evaluate access to MII essential information and to monitor an increase in the informed population in Indonesia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.